If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
20
Followers on Owler
Lilly Oncology
provides medicines for lung and stomach cancer...
Read more
Overview
Competitors
News & Insights
Lilly Oncology
provides medicines for lung and stomach cancer...
Read more
President & CEO
Jake Van Naarden
CEO Approval Rating
- -/100
Weigh In
2003
Indianapolis
Indiana
Indianapolis Metropolitan Area
Private
Pharmaceuticals & Biotechnology
Pharmaceuticals
2834
NAICS listing
http://lillyoncology.com/
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
News
Latest News
Jun 09, 2020
360DX
Lilly Oncology: NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program
May 14, 2020
PR Newswire
Press Release: Lilly Oncology : Lilly Oncology Showcases Innovation in Cancer Research at ASCO 2020
Sep 10, 2019
Pharmabiz
Lilly Oncology: Thermo Fisher inks pact with Lilly Oncology for companion diagnostic to be used with RET inhibitor
Jan 31, 2019
PR Newswire
Press Release: Lilly Oncology : FDA Expands Lilly's ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer
Dec 03, 2018
PR Newswire
Press Release: Lilly Oncology : NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment
Aug 31, 2018
The Pharma Letter
Lilly Oncology: Anne White to become new head of Lilly Oncology
Jun 05, 2018
BioPortfolio
Lilly: Sue Mahony to retire as president of Lilly Oncology
Mar 15, 2018
PMLiVE
Lilly: Lilly appoints Maura Dickler as VP of late phase oncology development
Oct 16, 2017
PR Newswire
Press Release: Lilly : Rapidly Progressing Advanced Non-Small Cell Lung Cancer Patients Shown to Benefit in New CYRAMZA® (ramucirumab) Phase 3 Subgroup Analysis
Jul 25, 2017
Inside INdiana Business
Lilly: Lilly Oncology Taking 'Aggressive' Position
Follow and Get Alerts
Lilly Oncology Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 13 + competitors
Trending Companies